Mazdutide: Dosage & Administration
Part of the Mazdutide Complete Guide
Research Peptides
We may earn a commission if you purchase through this link, at no extra cost to you.
Dosage Protocols
| Phase | Dose | Route | Frequency |
|---|---|---|---|
| Phase 2 (T2D) | 3–6 mg | SC injection | Weekly |
| Phase 3 (Obesity) | 4.5–6 mg | SC injection | Weekly |
Dose escalation over 8–12 weeks to minimize GI side effects. Not commercially available — all dosing from published trial protocols.
Administration
Clinical trial formulations are pre-filled injection pens. Mazdutide is not available as a research peptide for reconstitution. Subcutaneous injection in abdomen, thigh, or upper arm.
Timing
Weekly injection on the same day each week. Long-term continuous use anticipated (similar to GLP-1 agonist paradigm). Phase 3 trials evaluate 48-week treatment periods.
Storage
- Clinical formulations: 2–8°C
- Do not freeze
- Protect from light